ArticleJournal of clinical medicine2026

From Clinical Trial Efficacy to Real-World Effectiveness and Safety: Two-Year Outcomes of Cladribine in Relapsing-Remitting Multiple Sclerosis.

Duygu Özkan Yaşargün et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.